Hydrate deliberately
(Wegovy, Mounjaro & the New Pill, 2026) Updated 22/06/26 Based on the available clinical evidence, Mounjaro (tirzepatide) and Wegovy (semaglutide) are both well tolerated, but most people find Mounjaro causes fewer gastrointestinal side effects at comparable doses, with lower rates of nausea and a higher likelihood of completing treatment
For most patients, the starting dose is administered once weekly, often at a low microgram level prescribed by the healthcare provider
However, if the reaction seems severe or worsens over time, its vital to reach out to your healthcare provider
Research approved by the FDA showed semaglutide caused an average of about 15 percent weight loss over 68 weeks
Appetite Regulation GLP-1 therapy works by influencing the brains appetite centers, reducing hunger and controlling cravings